Overview
The main objectives are:
- To establish the prevalence of major bleeding in patients treated with higher than recommended thromboprophylaxis doses.
- To identify variables associated to higher risk of bleeding.
Eligibility
Inclusion Criteria:
- Patients infected with COVID-19 treated with higher than recommended thromboprophylaxis doses.
- Admission to hospital.
Exclusion Criteria:
- Patients treated with ECMO (Extracorporeal membrane oxygenation).